2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$0.94+$0.02 (+2.17%)
Price as of Jun 23, 2026 7:58 PM EDT- $52.8MMarket Cap
- -45.18%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$0.94+$0.02 (+2.17%)
TCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.92 | ||
Change | +$0.06 (+6.46%) | ||
Open | $0.87 | ||
High | $0.95 | ||
Low | $0.87 | ||
Previous Close | $0.87 | ||
Volume | 513,421 | ||
30-Day Average Volume | 493,429 | ||
1-Week Change | 8.60% | ||
1-Month Change | -13.11% | ||
1-Year Change | -45.18% | ||
3-Year Change | -65.89% | ||
5-Year Change | -96.33% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $202.0M | ||
Market Cap | $52.8M | ||
Enterprise Value | -$42.6M | ||
Period: QTR TTM FY | |||
Revenue | $982,000.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$24.3M | ||
EBIT | -$28.0M | ||
EBITDA | -$27.3M | ||
Net Working Capital | $112.8M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -43 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue